Levodopa-induced dyskinesias in Parkinson's disease: Is sensitization reversible?
โ Scribed by Boulos-Paul Bejjani; Isabelle Arnulf; Sophie Demeret; Philippe Damier; Anne-Marie Bonnet; Jean-Luc Houeto; Yves Agid
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 992 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We thank Dr. Jabre and his colleagues for their comments concerning our article 1 and the reduction of the levodopa response after bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in the long-term follow-up. We also agree that this partial loss of the levodopa clinical benefit after
Our objective was to develop parameters for objective ambulatory measurements of levodopa-induced dyskinesias (LID) in patients with Parkinson's disease (PD). Twentythree PD patients with mild to severe LID were submitted to a standardized protocol of 1-minute recordings during rest, talking, stress
Symptomatic respiratory disturbance as a consequence of levodopa (L-dopa) therapy for Parkinson's disease (PD) has been described only rarely and may be underrecognized in clinical practice. We report on two patients with PD in whom the introduction or augmentation of L-dopa therapy was associated w